Efficacy and safety of each class of sleep medication for major depressive disorder with insomnia symptoms: A systematic review and meta‐analysis of double‐blind randomized controlled trials

Documenti analoghi

• Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms
  di: Andrew Krystal, et al.
  Pubblicazione: (2024)
• Relationship between depression improvement and activities of daily living recovery in patients with fractures
  di: Shunji Araki, et al.
  Pubblicazione: (2025)
• Higher discontinuation with dual orexin receptor antagonists than with benzodiazepines: A Japanese claims cohort study
  di: Kazuhiro Kurihara, et al.
  Pubblicazione: (2025)
• A psychometric analysis of the Japanese version of the clinically useful depression outcome scale supplemented with questions for the DSM‐5 anxious distress specifier (CUDOS‐A)
  di: Yumi Aoki, et al.
  Pubblicazione: (2024)
• Effects of policy interventions on psychotropic polypharmacy in Japanese older adults
  di: Masahiro Takeshima, et al.
  Pubblicazione: (2024)